Shanghai Medicilon Inc.(688202),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

688202 Shanghai Medicilon Inc.

Closed 01-21 15:00:01

63.45

+0.27

+0.43%

High64.85	Low62.27	Vol3.47M
Open63.12	D1 Closing63.18	Amplitude4.08%
Mkt Cap8.50B	Tradable Cap8.50B	Total Shares134.00M
T/O221.00M	T/O Rate2.59%	Tradable Shares134.00M
P/B4.13	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"688202","market":"SH","secType":"STK","nameCN":"Shanghai Medicilon Inc.","latestPrice":63.45,"timestamp":1768978801000,"preClose":63.18,"halted":0,"volume":3466302,"delay":0,"changeRate":0.0043,"floatShares":134000000,"shares":134000000,"eps":-1.7258,"marketStatus":"Closed","change":0.27,"latestTime":"01-21 15:00:01","open":63.12,"high":64.85,"low":62.27,"amount":221000000,"amplitude":0.0408,"askPrice":63.48,"askSize":16,"bidPrice":63.45,"bidSize":9,"shortable":0,"etf":0,"ttmEps":-1.7258,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769045400000},"marketStatusCode":5,"adr":0,"adjPreClose":63.18,"symbolType":"stock_kcb","openAndCloseTimeList":[[1768959000000,1768966200000],[1768971600000,1768978800000]],"highLimit":69.5,"lowLimit":56.86,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":134352184,"isCdr":false,"pbRate":4.13,"roa":"--","roe":"--","epsLYR":-2.47,"committee":-0.059952,"marketValue":8525000000,"turnoverRate":0.0258,"status":0,"afterMarket":{"amount":0,"volume":0,"close":63.45,"buyVolume":200,"sellVolume":0,"time":1768980837919,"indexStatus":"Closed 01-21 15:30:00","preClose":63.18},"floatMarketCap":8525000000},"requestUrl":"/m/hq/s/688202","defaultTab":"news","newsList":[{"id":"1186540173","title":"Shanghai Medicilon Inc. (688202.SH) Shareholder Chen Guoxing Plans to Reduce Holdings by Up to 1.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186540173","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186540173?lang=en_us&edition=fundamental","pubTime":"2025-11-19 18:52","pubTimestamp":1763549535,"startTime":"0","endTime":"0","summary":"Shanghai Medicilon Inc. (688202.SH) announced that shareholder Chen Guoxing intends to reduce his holdings by no more than 2.2 million shares, or 1.64% of the company's total shares, through centralized bidding and block trades due to personal funding needs.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","688202"],"gpt_icon":0},{"id":"1108594510","title":"Shanghai Medicilon Inc. Shareholder Lin Changqing Reduces Stake by 1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1108594510","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108594510?lang=en_us&edition=fundamental","pubTime":"2025-11-11 17:41","pubTimestamp":1762854110,"startTime":"0","endTime":"0","summary":"On November 11, Shanghai Medicilon Inc. (688202) announced that shareholder Lin Changqing reduced his stake in the company by a total of 1.54 million shares, accounting for 1.15% of the company's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","688202"],"gpt_icon":0},{"id":"1139557951","title":"Shanghai Medicilon Inc. Faces 159 Million Yuan Lawsuit as Hongxu Biomedical Claims Severe Losses from Delayed Deliveries","url":"https://stock-news.laohu8.com/highlight/detail?id=1139557951","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139557951?lang=en_us&edition=fundamental","pubTime":"2025-09-19 15:21","pubTimestamp":1758266472,"startTime":"0","endTime":"0","summary":"Hongxu Biomedical Technology (Beijing) Co., Ltd. (hereinafter referred to as \"Hongxu Biomedical\") recently issued a statement clarifying the litigation situation involving Shanghai Medicilon Inc.'s...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","688202"],"gpt_icon":0},{"id":"1155760911","title":"Billion-Yuan Lawsuit Ignites GLP-1 R&D Battle! Shanghai Medicilon Faces Client Backlash as Trust Crisis Emerges in CRO Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=1155760911","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155760911?lang=en_us&edition=fundamental","pubTime":"2025-09-12 15:01","pubTimestamp":1757660467,"startTime":"0","endTime":"0","summary":"As domestic pharmaceutical companies rush into the competitive GLP-1 weight-loss drug development market, a crack in the collaboration chain is quietly spreading. On September 5th, CRO company...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688202","BK4144","BK0216","BK4590","GLP"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-11-05","address":"上海市浦东新区中国(上海)自由贸易试验区李冰路67弄5号楼","stockEarnings":[{"period":"1week","weight":-0.1194},{"period":"1month","weight":0.1151},{"period":"3month","weight":0.0219},{"period":"6month","weight":-0.0208},{"period":"1year","weight":1.2726},{"period":"ytd","weight":0.125}],"companyName":"上海美迪西生物医药股份有限公司","boardCode":"AI0073","perCapita":"8149股","boardName":"研究和试验发展","registeredCapital":"13435万元","compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0509},{"period":"3month","weight":0.0496},{"period":"6month","weight":0.1456},{"period":"1year","weight":0.2696},{"period":"ytd","weight":0.0373}],"survey":"　　上海美迪西生物医药股份有限公司的主营业务是通过研发技术平台向药企及科研单位提供药物发现与药学研究、临床前研究的医药研发服务。公司的主要产品是临床前CRO业务。","serverTime":1769035652395,"listedPrice":41.5,"stockholders":"16485人(较上一季度增加27.83%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Shanghai Medicilon Inc.(688202),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Shanghai Medicilon Inc.(688202) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Shanghai Medicilon Inc.,688202,Shanghai Medicilon Inc.股票,Shanghai Medicilon Inc.股票老虎,Shanghai Medicilon Inc.股票老虎国际,Shanghai Medicilon Inc.行情,Shanghai Medicilon Inc.股票行情,Shanghai Medicilon Inc.股价,Shanghai Medicilon Inc.股市,Shanghai Medicilon Inc.股票价格,Shanghai Medicilon Inc.股票交易,Shanghai Medicilon Inc.股票购买,Shanghai Medicilon Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Shanghai Medicilon Inc.(688202),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Shanghai Medicilon Inc.(688202) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction